penetrate the gap between the helmet and head
Denver, CO (PRWEB) December 11, 2008
Denver, CO -- LegalView, the number one resource for everything and anything legal, recently reported the negative results of a study that found helmets might worsen a traumatic brain injury (TBI) among soldiers in Iraq and even act as a "focusing mechanism" for shockwaves during a blast caused by an improvised explosive device (IED). The results of the study were reported during the 61st Meeting of the American Physical Society's Division of Fluid Dynamics at the San Antonio Naval Research Laboratory (NRL). The study reported that shockwaves emanating from an IED explosion may "penetrate the gap between the helmet and head" causing an increased number of shockwaves under the helmet and outside of the helmet worsening the traumatic brain injury that can occur, according to the TBI information blog.
Those who have suffered from TBI should consider consulting an experienced brain injury law firm that can provide contact to an array of knowledgeable brain injury lawyers and brain injury attorneys who can provide a free legal consultation as to the development of a TBI lawsuit.
Individuals who are also in need of additional information on other legal topics can find assistance through the LegalView library of information portals, with topics including the latest on Nephrogenic Systemic Fibrosis, Avandia and Byetta.
Nephrogenic Systemic Fibrosis (NSF) is a rare and extremely crippling condition that is commonly attributed to the administration of gadolinium dyes during magnetic resonance imaging and magnetic resonance angiography (MRI/MRA) procedures among kidney disease patients. The condition can cause patients skin to thicken and swell eventually disabling the joints from moving. Those who suffer from the NSF side effects can consult with a personal injury attorney and likely receive a free legal consultation as to the development of a potential NSF lawsuit that may offer a return of monetary compensation to assist in paying for NSF treatments.
Avandia and Byetta are both type 2 diabetes prescription medications, however, each has been making news headlines for very different reasons. Avandia, from GlaxoSmithKline, was introduced to the market in 1999. In 2007, a New England Journal of Medicine article reported that consumption of Avandia allegedly increases the risk of heart disease among patients. Additionally, a Swiss study announced that Avandia also may allegedly increase the risk of bone breaks and fractures during consumption of Avandia. Those consuming Avandia may want to speak with their physician regarding the alleged Avandia side effects.
Also in 2007, approximately 30 patients reported to the FDA that they suffered from pancreatic inflammation while consuming Byetta, the type 2 diabetes medication. In 2008, again, six patients were hospitalized with acute pancreatitis all of whom were consuming Byetta. The FDA is investigating the claims of an alleged link between Byetta and the development of pancreas disorders, but patients are advised to speak with their doctor as well as to an experienced Byetta attorney.
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at http://www.LegalView.com.